CN110343703B - 三疣梭子蟹C型凝集素PtCLec1基因及其编码蛋白和应用 - Google Patents
三疣梭子蟹C型凝集素PtCLec1基因及其编码蛋白和应用 Download PDFInfo
- Publication number
- CN110343703B CN110343703B CN201910644066.7A CN201910644066A CN110343703B CN 110343703 B CN110343703 B CN 110343703B CN 201910644066 A CN201910644066 A CN 201910644066A CN 110343703 B CN110343703 B CN 110343703B
- Authority
- CN
- China
- Prior art keywords
- ptclec1
- gene
- portunus trituberculatus
- type lectin
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 63
- 241001533364 Portunus trituberculatus Species 0.000 title claims abstract description 50
- 102000003930 C-Type Lectins Human genes 0.000 title claims abstract description 34
- 108090000342 C-Type Lectins Proteins 0.000 title claims abstract description 34
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 19
- 241000894006 Bacteria Species 0.000 claims abstract description 18
- 230000027455 binding Effects 0.000 claims abstract description 16
- 241000191938 Micrococcus luteus Species 0.000 claims abstract description 13
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims abstract description 13
- 241000607594 Vibrio alginolyticus Species 0.000 claims abstract description 13
- 241000607272 Vibrio parahaemolyticus Species 0.000 claims abstract description 13
- 241000191967 Staphylococcus aureus Species 0.000 claims abstract description 12
- 241000235058 Komagataella pastoris Species 0.000 claims abstract description 11
- 230000004520 agglutination Effects 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000003259 recombinant expression Methods 0.000 claims description 6
- 229940124350 antibacterial drug Drugs 0.000 claims description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract description 30
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract description 30
- 239000002299 complementary DNA Substances 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 13
- 238000012163 sequencing technique Methods 0.000 abstract description 13
- 241000238097 Callinectes sapidus Species 0.000 abstract description 10
- 230000003321 amplification Effects 0.000 abstract description 8
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 8
- 241000192125 Firmicutes Species 0.000 abstract description 4
- 230000003385 bacteriostatic effect Effects 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 230000005764 inhibitory process Effects 0.000 abstract description 3
- 230000029586 bacterial cell surface binding Effects 0.000 abstract 1
- 238000004458 analytical method Methods 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 238000004925 denaturation Methods 0.000 description 12
- 230000036425 denaturation Effects 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 8
- 241000233866 Fungi Species 0.000 description 8
- 238000000137 annealing Methods 0.000 description 8
- 239000011575 calcium Substances 0.000 description 8
- 238000012258 culturing Methods 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 150000001413 amino acids Chemical group 0.000 description 6
- 239000007853 buffer solution Substances 0.000 description 6
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 101710186708 Agglutinin Proteins 0.000 description 4
- 101710146024 Horcolin Proteins 0.000 description 4
- 101710189395 Lectin Proteins 0.000 description 4
- 101710179758 Mannose-specific lectin Proteins 0.000 description 4
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 4
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000000910 agglutinin Substances 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000002523 lectin Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 102000007863 pattern recognition receptors Human genes 0.000 description 4
- 108010089193 pattern recognition receptors Proteins 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241001052560 Thallis Species 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000007124 immune defense Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical class [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 102000004856 Lectins Human genes 0.000 description 2
- 108090001090 Lectins Proteins 0.000 description 2
- HCTXJGRYAACKOB-SRVKXCTJSA-N Phe-Asn-Asp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N HCTXJGRYAACKOB-SRVKXCTJSA-N 0.000 description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 description 2
- 108091034057 RNA (poly(A)) Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000012474 protein marker Substances 0.000 description 2
- 238000004153 renaturation Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- RMAWDDRDTRSZIR-ZLUOBGJFSA-N Ala-Ser-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RMAWDDRDTRSZIR-ZLUOBGJFSA-N 0.000 description 1
- KTXKIYXZQFWJKB-VZFHVOOUSA-N Ala-Thr-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O KTXKIYXZQFWJKB-VZFHVOOUSA-N 0.000 description 1
- KUFVXLQLDHJVOG-SHGPDSBTSA-N Ala-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C)N)O KUFVXLQLDHJVOG-SHGPDSBTSA-N 0.000 description 1
- IGULQRCJLQQPSM-DCAQKATOSA-N Arg-Cys-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O IGULQRCJLQQPSM-DCAQKATOSA-N 0.000 description 1
- IGFJVXOATGZTHD-UHFFFAOYSA-N Arg-Phe-His Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc2c[nH]cn2)C(=O)O IGFJVXOATGZTHD-UHFFFAOYSA-N 0.000 description 1
- UVTGNSWSRSCPLP-UHFFFAOYSA-N Arg-Tyr Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O UVTGNSWSRSCPLP-UHFFFAOYSA-N 0.000 description 1
- UGXVKHRDGLYFKR-CIUDSAMLSA-N Asn-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(N)=O UGXVKHRDGLYFKR-CIUDSAMLSA-N 0.000 description 1
- XXAOXVBAWLMTDR-ZLUOBGJFSA-N Asn-Cys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)N)N XXAOXVBAWLMTDR-ZLUOBGJFSA-N 0.000 description 1
- FTCGGKNCJZOPNB-WHFBIAKZSA-N Asn-Gly-Ser Chemical compound NC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FTCGGKNCJZOPNB-WHFBIAKZSA-N 0.000 description 1
- TZFQICWZWFNIKU-KKUMJFAQSA-N Asn-Leu-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 TZFQICWZWFNIKU-KKUMJFAQSA-N 0.000 description 1
- MRQQMVZUHXUPEV-IHRRRGAJSA-N Asp-Arg-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O MRQQMVZUHXUPEV-IHRRRGAJSA-N 0.000 description 1
- NAPNAGZWHQHZLG-ZLUOBGJFSA-N Asp-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)N NAPNAGZWHQHZLG-ZLUOBGJFSA-N 0.000 description 1
- OMMIEVATLAGRCK-BYPYZUCNSA-N Asp-Gly-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)NCC(O)=O OMMIEVATLAGRCK-BYPYZUCNSA-N 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- VXLXATVURDNDCG-CIUDSAMLSA-N Cys-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CS)N VXLXATVURDNDCG-CIUDSAMLSA-N 0.000 description 1
- IWVNIQXKTIQXCT-SRVKXCTJSA-N Cys-Tyr-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CS)N)O IWVNIQXKTIQXCT-SRVKXCTJSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- DOQUICBEISTQHE-CIUDSAMLSA-N Gln-Pro-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O DOQUICBEISTQHE-CIUDSAMLSA-N 0.000 description 1
- JTWZNMUVQWWGOX-SOUVJXGZSA-N Gln-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCC(=O)N)N)C(=O)O JTWZNMUVQWWGOX-SOUVJXGZSA-N 0.000 description 1
- CAVMESABQIKFKT-IUCAKERBSA-N Glu-Gly-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)N CAVMESABQIKFKT-IUCAKERBSA-N 0.000 description 1
- CBOVGULVQSVMPT-CIUDSAMLSA-N Glu-Pro-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O CBOVGULVQSVMPT-CIUDSAMLSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 108010053070 Glutathione Disulfide Proteins 0.000 description 1
- UXJHNZODTMHWRD-WHFBIAKZSA-N Gly-Asn-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O UXJHNZODTMHWRD-WHFBIAKZSA-N 0.000 description 1
- LCNXZQROPKFGQK-WHFBIAKZSA-N Gly-Asp-Ser Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O LCNXZQROPKFGQK-WHFBIAKZSA-N 0.000 description 1
- IDOGEHIWMJMAHT-BYPYZUCNSA-N Gly-Gly-Cys Chemical compound NCC(=O)NCC(=O)N[C@@H](CS)C(O)=O IDOGEHIWMJMAHT-BYPYZUCNSA-N 0.000 description 1
- TVUWMSBGMVAHSJ-KBPBESRZSA-N Gly-Leu-Phe Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 TVUWMSBGMVAHSJ-KBPBESRZSA-N 0.000 description 1
- WSWWTQYHFCBKBT-DVJZZOLTSA-N Gly-Thr-Trp Chemical compound C[C@@H](O)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O WSWWTQYHFCBKBT-DVJZZOLTSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- BFOGZWSSGMLYKV-DCAQKATOSA-N His-Ser-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CN=CN1)N BFOGZWSSGMLYKV-DCAQKATOSA-N 0.000 description 1
- GYXDQXPCPASCNR-NHCYSSNCSA-N His-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N GYXDQXPCPASCNR-NHCYSSNCSA-N 0.000 description 1
- 101000894534 Hyphantria cunea Beta-1,3-glucan-binding protein Proteins 0.000 description 1
- ZZHGKECPZXPXJF-PCBIJLKTSA-N Ile-Asn-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ZZHGKECPZXPXJF-PCBIJLKTSA-N 0.000 description 1
- LDRALPZEVHVXEK-KBIXCLLPSA-N Ile-Cys-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N LDRALPZEVHVXEK-KBIXCLLPSA-N 0.000 description 1
- OUUCIIJSBIBCHB-ZPFDUUQYSA-N Ile-Leu-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O OUUCIIJSBIBCHB-ZPFDUUQYSA-N 0.000 description 1
- BQIIHAGJIYOQBP-YFYLHZKVSA-N Ile-Trp-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N3CCC[C@@H]3C(=O)O)N BQIIHAGJIYOQBP-YFYLHZKVSA-N 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- ZRLUISBDKUWAIZ-CIUDSAMLSA-N Leu-Ala-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O ZRLUISBDKUWAIZ-CIUDSAMLSA-N 0.000 description 1
- XIRYQRLFHWWWTC-QEJZJMRPSA-N Leu-Ala-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XIRYQRLFHWWWTC-QEJZJMRPSA-N 0.000 description 1
- IZPVWNSAVUQBGP-CIUDSAMLSA-N Leu-Ser-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IZPVWNSAVUQBGP-CIUDSAMLSA-N 0.000 description 1
- AIQWYVFNBNNOLU-RHYQMDGZSA-N Leu-Thr-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O AIQWYVFNBNNOLU-RHYQMDGZSA-N 0.000 description 1
- MVJRBCJCRYGCKV-GVXVVHGQSA-N Leu-Val-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O MVJRBCJCRYGCKV-GVXVVHGQSA-N 0.000 description 1
- DEFGUIIUYAUEDU-ZPFDUUQYSA-N Lys-Asn-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DEFGUIIUYAUEDU-ZPFDUUQYSA-N 0.000 description 1
- RDIILCRAWOSDOQ-CIUDSAMLSA-N Lys-Cys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)O)N RDIILCRAWOSDOQ-CIUDSAMLSA-N 0.000 description 1
- LKDXINHHSWFFJC-SRVKXCTJSA-N Lys-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)N LKDXINHHSWFFJC-SRVKXCTJSA-N 0.000 description 1
- SXWQMBGNFXAGAT-FJXKBIBVSA-N Met-Gly-Thr Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O SXWQMBGNFXAGAT-FJXKBIBVSA-N 0.000 description 1
- XPVCDCMPKCERFT-GUBZILKMSA-N Met-Ser-Arg Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O XPVCDCMPKCERFT-GUBZILKMSA-N 0.000 description 1
- PESQCPHRXOFIPX-UHFFFAOYSA-N N-L-methionyl-L-tyrosine Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-UHFFFAOYSA-N 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102000052544 Peptidoglycan recognition protein Human genes 0.000 description 1
- 108010009051 Peptidoglycan recognition protein Proteins 0.000 description 1
- JJHVFCUWLSKADD-ONGXEEELSA-N Phe-Gly-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](C)C(O)=O JJHVFCUWLSKADD-ONGXEEELSA-N 0.000 description 1
- 101000894541 Plodia interpunctella Beta-1,3-glucan-binding protein Proteins 0.000 description 1
- YYARMJSFDLIDFS-FKBYEOEOSA-N Pro-Phe-Trp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O YYARMJSFDLIDFS-FKBYEOEOSA-N 0.000 description 1
- IIRBTQHFVNGPMQ-AVGNSLFASA-N Pro-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 IIRBTQHFVNGPMQ-AVGNSLFASA-N 0.000 description 1
- 241001672730 Scylla paramamosain Species 0.000 description 1
- IFPBAGJBHSNYPR-ZKWXMUAHSA-N Ser-Ile-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O IFPBAGJBHSNYPR-ZKWXMUAHSA-N 0.000 description 1
- UIPXCLNLUUAMJU-JBDRJPRFSA-N Ser-Ile-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O UIPXCLNLUUAMJU-JBDRJPRFSA-N 0.000 description 1
- CUXJENOFJXOSOZ-BIIVOSGPSA-N Ser-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CO)N)C(=O)O CUXJENOFJXOSOZ-BIIVOSGPSA-N 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- BSNZTJXVDOINSR-JXUBOQSCSA-N Thr-Ala-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BSNZTJXVDOINSR-JXUBOQSCSA-N 0.000 description 1
- QGXCWPNQVCYJEL-NUMRIWBASA-N Thr-Asn-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QGXCWPNQVCYJEL-NUMRIWBASA-N 0.000 description 1
- XPNSAQMEAVSQRD-FBCQKBJTSA-N Thr-Gly-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)NCC(O)=O XPNSAQMEAVSQRD-FBCQKBJTSA-N 0.000 description 1
- PELIQFPESHBTMA-WLTAIBSBSA-N Thr-Tyr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 PELIQFPESHBTMA-WLTAIBSBSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 102000002689 Toll-like receptor Human genes 0.000 description 1
- 108020000411 Toll-like receptor Proteins 0.000 description 1
- DXDMNBJJEXYMLA-UBHSHLNASA-N Trp-Asn-Asp Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O)=CNC2=C1 DXDMNBJJEXYMLA-UBHSHLNASA-N 0.000 description 1
- OBWQLWYNNZPWGX-QEJZJMRPSA-N Trp-Gln-Asp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O OBWQLWYNNZPWGX-QEJZJMRPSA-N 0.000 description 1
- KIMOCKLJBXHFIN-YLVFBTJISA-N Trp-Ile-Gly Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O)=CNC2=C1 KIMOCKLJBXHFIN-YLVFBTJISA-N 0.000 description 1
- BXPOOVDVGWEXDU-WZLNRYEVSA-N Tyr-Ile-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BXPOOVDVGWEXDU-WZLNRYEVSA-N 0.000 description 1
- XJPXTYLVMUZGNW-IHRRRGAJSA-N Tyr-Pro-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O XJPXTYLVMUZGNW-IHRRRGAJSA-N 0.000 description 1
- XFEMMSGONWQACR-KJEVXHAQSA-N Tyr-Thr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O XFEMMSGONWQACR-KJEVXHAQSA-N 0.000 description 1
- ASQFIHTXXMFENG-XPUUQOCRSA-N Val-Ala-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O ASQFIHTXXMFENG-XPUUQOCRSA-N 0.000 description 1
- CKTMJBPRVQWPHU-JSGCOSHPSA-N Val-Phe-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O)N CKTMJBPRVQWPHU-JSGCOSHPSA-N 0.000 description 1
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 210000005006 adaptive immune system Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 108010092854 aspartyllysine Proteins 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 1
- 108010084264 glycyl-glycyl-cysteine Proteins 0.000 description 1
- 108010066198 glycyl-leucyl-phenylalanine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010084389 glycyltryptophan Proteins 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- -1 hemoxins Proteins 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 108010076756 leucyl-alanyl-phenylalanine Proteins 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 102000014452 scavenger receptors Human genes 0.000 description 1
- 108010078070 scavenger receptors Proteins 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 238000011222 transcriptome analysis Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3526—Organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Animal Husbandry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明属于分子生物学技术领域,具体是一种三疣梭子蟹C型凝集素PtCLec1基因及其编码蛋白和应用。本发明利用转录组测序获得的unigene和RACE技术从三疣梭子蟹中扩增得到PtCLec1基因cDNA,重组的PtCLec1蛋白具有显著的抑菌、菌结合、菌凝集活性。重组蛋白PtCLec1对革兰氏阴性菌和革兰氏阳性菌具有明显的抑制效果。重组蛋白PtCLec1对溶藻弧菌、副溶血弧菌、铜绿假单胞菌、藤黄微球菌和毕赤酵母菌均具有明显的结合活力。在Ca2+存在下,重组蛋白PtCLec1对溶藻弧菌、副溶血弧菌、铜绿假单胞菌、金黄色葡萄球菌、藤黄微球菌和毕赤酵母菌均具有明显的凝集效果。
Description
技术领域
本发明属于分子生物学技术领域,具体的说是一种三疣梭子蟹C型凝集素PtCLec1基因及其编码蛋白和应用。
背景技术
无脊椎动物缺乏适应性免疫系统,它识别“非己”物质主要是依靠模式识别受体(PRRs)识别病原相关分子模式(PAMPs)来完成的。无脊椎动物模式识别受体主要包括:肽聚糖识别蛋白、革兰氏阴性菌结合蛋白、含硫酯键蛋白、清道夫受体、硫依赖型凝集素、血素、Toll样受体和C型凝集素。C型凝集素是一类钙离子依赖蛋白,该类蛋白均具有一个能够识别并结合糖类的糖类识别结构域(CRD)。CRD结构域中一般含有非常保守的四个半胱氨酸,并通过它们形成两对二硫键,以维持整个结构域的构象。CRD结构域含有4个Ca2+结合位点,其中Ca2+结合位点2的作用最重要,主要参与对糖类底物的结合。Ca2+结合位点2是由两个高保守的基序组成,第一个基序是EPN或QPD,分别特异性结合甘露糖或半乳糖;另一个基序是WND,主要参与钙离子的结合并维持疏水核心。
三疣梭子蟹是一种重要的海产经济蟹类,由于其营养价值丰富、生长迅速等优点,已成为我国重要海水养殖品种。近年来,三疣梭子蟹受弧菌等病原菌的影响病害频发,严重制约梭子蟹养殖业的发展。甲壳动物缺乏抗体和特异性免疫细胞,主要依靠先天免疫清除病原微生物,进行免疫防御。目前关于三疣梭子蟹C型凝集素的研究尚少,其Ca2+结合位点2基序的变异对基因功能的影响尚不清楚。因此,模式识别受体C型凝集素的发掘和利用对理解三疣梭子蟹的免疫防御机制、进行病害防治具有重要的理论和实践意义。
发明内容
本发明旨在提供一种三疣梭子蟹C型凝集素PtCLec1基因及其编码蛋白和应用。
为实现上述目的,本发明采用的技术方案为:
一种三疣梭子蟹C型凝集素PtCLec1基因,三疣梭子蟹C型凝集素PtCLec1基因为序列表SEQ ID No.1中的碱基序列所示。
一种三疣梭子蟹C型凝集素PtCLec1基因编码蛋白,所述PtCLec1基因编码蛋白为序列表SEQ ID No.2中的氨基酸序列所示。
一种三疣梭子蟹C型凝集素PtCLec1基因编码蛋白的应用,所述三疣梭子蟹C型凝集素PtCLec1基因的重组表达产物可制备为抗菌药物、免疫活性剂、饲料添加剂、防腐剂或保鲜剂。
所述三疣梭子蟹C型凝集素PtCLec1基因的重组表达产物可用于制备革兰氏阴性菌或革兰氏阳性菌的抗菌药物、菌结合制剂或凝集制剂。
所述革兰氏阴性菌为溶藻弧菌、副溶血弧菌或铜绿假单胞菌;革兰氏阳性菌为金黄色葡萄球菌或藤黄微球菌。
所述三疣梭子蟹C型凝集素PtCLec1基因的重组表达产物可用于制备真菌的凝集制剂。
所述真菌为毕赤酵母菌。
本发明所具有的优点:
本发明获得PtCLec1基因及其重组蛋白可生产抑菌药物、菌凝集制剂等,应用于水产养殖过程中相关虾蟹疾病的治疗,或用于饲料添加剂、防腐剂或保鲜剂的生产等,另外还可以为进一步研究三疣梭子蟹免疫防御机制提供基础,并为三疣梭子蟹的病害防治和基因辅助选育提供参考;具体为:
本发明PtCLec1基因利用转录组测序获得的unigene和RACE技术从三疣梭子蟹中克隆到PtCLec1基因cDNA全长序列,通过PCR技术扩增编码PtCLec1成熟肽的基因片段并将其克隆到pET32a(+)表达载体中,在大肠杆菌BL21(DE3)-plysS实现体外重组表达。重组蛋白PtCLec1经TALON柱纯化和透析后,对革兰氏阴性菌(溶藻弧菌、副溶血弧菌、铜绿假单胞菌)、革兰氏阳性菌(金黄色葡萄球菌、藤黄微球菌)和真菌(毕赤酵母菌)均具有结合和凝集活力,尤其是对革兰氏阴性菌的效果十分明显。重组蛋白PtCLec1对溶藻弧菌、副溶血弧菌、铜绿假单胞菌、金黄色葡萄球菌和藤黄微球菌均有明显的抑制作用,最小抑菌浓度分别为0.48~0.96μM、1.92~3.85μM、0.96~1.92μM、1.92~3.85μM、0.96~1.92μM。
附图说明
图1为本发明实例提供的三疣梭子蟹C型凝集素PtCLec1基因的核苷酸和氨基酸序列(红色下划线:起始密码子和终止密码子;灰色阴影部分:信号肽;黑框:Ca2+结合位点;黑色阴影:氨基酸保守基序)。
图2为本发明实例提供的纯化后三疣梭子蟹C型凝集素PtCLec1编码成熟肽的基因扩增产物(其中,M:DNA marker,1、2:成熟肽的基因扩增产物)。
图3为本发明实例提供的诱导和纯化后三疣梭子蟹C型凝集素PtCLec1重组蛋白(其中M:蛋白marker;1:IPTG诱导后pET-32a空质粒表达的蛋白;2:未诱导PtCLec1菌体中表达的蛋白;3:IPTG诱导后PtCLec1表达的蛋白;4:纯化的PtCLec1重组蛋白)。
图4为本发明实例三疣梭子蟹C型凝集素PtCLec1重组蛋白对细菌、真菌结合活力作用图(其中M:蛋白marker;E:微生物与PtCLec1重组蛋白的洗脱液;S:微生物与重组蛋白孵育离心后上清液;W:微生物与PtCLec1重组蛋白孵育后洗涤液)。
图5为本发明实例三疣梭子蟹C型凝集素PtCLec1重组蛋白对细菌和真菌凝集活性作用图(检测荧光标记的溶藻弧菌、副溶血弧菌、铜绿假单胞菌、藤黄微球菌、金黄色葡萄球菌和毕赤酵母菌,rPtCLec1、rTrx、CaCl2和EDTA分别是25nmol L-1、25nmol L-1、10mmol L-1和10mmol L-1,PBS和rTrx分别作为空白和阴性对照)。
具体实施方式
下面的实施例中将本发明作进一步阐述,但本发明不限于此。
本发明中的三疣梭子蟹C型凝集素PtCLec1的cDNA序列克隆包括下列步骤:
a)三疣梭子蟹总RNA的提取及mRNA的检测;
b)三疣梭子蟹cDNA文库构建;
c)三疣梭子蟹转录组测序及分析;
d)三疣梭子蟹unigene序列的同源性分析及PtCLec1基因片段的筛选;
e)RACE扩增获得PtCLec1的全长序列以及全长序列的验证。
实施例1.
三疣梭子蟹C型凝集素PtCLec1基因为SEQ ID No.1中所示的碱基序列。
由图1可见,序列表SEQ ID No.1为:
GTAAGAATGACTGTTGGGTGTTTCTCCGTACAGCCACTCTTATGGGAAAGCCGGTCTGTTCGTAGTACAATGCAGAGATAGGGGTTCGGCTTGCGCAAGACGAGAGCACCAGCAAAACAGTCGTGCATATATGTAAGGTGGATCGCGGCACAGAACAGCACACATCCTCCTTCAGCTGCACACTTTGCCTCCACCTGCTCCGCCGCCAACACTTGCATCATGAGTCGCTACTTGCTCCTCGCATTCTTCGGAGCCTTGACTGTGGAGGCGACGACACATGTGAACTTATCTGACAGTATCTCCGGTGATTCTTCGGGGGGCTGCAGCTCCCCGTACACTATGGTTGCTGGCCGCTGCTTATACATTAACTTCGCTACCTCTGGCACTTGGGACCGCTTCCACTCCATGTACTGCAAAGACACAGGAGGGAATGACCTGGTGACAGTGGACGACGCTAACTTCCTTGCCGACCTTGTTCAGTACATCACAAGTATTGGATGGCAAGACGGTTTGTTCTGGATCGGTGCCTCGGACAAGAGTCACGAGGGCCACTGGATATGGCCTAACGGCTCCCCCGTCAAGATGGGTACACCCTTCTGGGGCACGTACGGCTGCTACAACCAGCAGTATCCCGATGGAGGAACCAATGAAAACTGCGCAATACTAGATGGAAATGCAAATCTATATTTCAACGACTTTAAATGTGACACAGCATTAGCTGTCTTCGGTATCTGCGAGAAGAATATCTAGGAAAATTATTGAGCTTATAATTTAGTAATAATGTATGTCACATATGATAAGCCATAAGAAGCAAGACAGGAAATGTACTCTAAAGCAATAAAAACGAAAATATAAAAAAAAAAAAAAAAAAAA
(a)序列特征
·长度:873bp(有效长度220~750bp)
·类型:碱基序列
·链型:单链
·拓扑结构:线性
(b)分子类型:双链DNA
(c)假设:否
(d)反义:否
(e)最初来源:三疣梭子蟹(Portunus trituberculatus)
(f)特异性名称:CDS
构建具体操作如下:
1.三疣梭子蟹总RNA的提取及mRNA纯化:利用Invitrogen公司的Trizol试剂提取三疣梭子蟹成体组织的总RNA。琼脂糖凝胶电泳分析RNA降解程度以及是否有污染,Nanodrop检测RNA的纯度,Qubit对RNA浓度进行精确定量,Agilent 2100精确检测RNA的完整性。
2.三疣梭子蟹cDNA文库构建:mRNA样品检测合格后,用带有Oligo(dT)的磁珠富集mRNA。随后加入fragmentation buffer将mRNA打断成短片段,以mRNA为模板,用六碱基随机引物合成一链cDNA,然后加入缓冲液、dNTPs和DNA polymerase I和RNase H合成二链cDNA,再用AMPure XP beads纯化双链cDNA。纯化的双链cDNA先进行末端修复、加A尾并连接测序接头,再用AMPure XP beads进行片段大小选择。最后进行PCR扩增,并用AMPure XP beads纯化PCR产物,得到最终的文库。
3.转录组测序及分析:cDNA文库检验合格后,把不同文库按照有效浓度及目标下机数据量的需求pooling后进行Illumina HiSeq/MiSeq测序。对于无参考基因组物种的转录组分析,先将测序所得的序列拼接成转录本,以转录本为参考序列,进行后续分析。高通量测序得到的原始图像数据文件经CASAVA碱基识别分析转化为原始测序序列,我们称之为Raw Data或Raw Reads。然而,原始测序序列中含有带接头的、低质量的reads。为了保证信息分析质量,必须对raw reads过滤得到clean reads,后续分析都基于clean reads。获得clean reads后,采用Trinity转录组拼接软件对clean reads进行拼接。取每条基因中最长的转录本作为unigene,以此进行后续的分析。后续分析包括基因功能注释(基因功能注释数据库包括Nr,Nt,Pfam,KOG/COG,Swiss-prot,KEGG,GO)、CDS预测、基因表达水平分析、直系同源基因筛选等生物信息学分析。
4.三疣梭子蟹unigene序列的同源性分析及PtCLec1基因片段的筛选:在三疣梭子蟹转录组中获得1条PtCLec1相关的unigene,将其在数据库中进行BLASTn和BLASTx分析,结果显示该序列与拟穴青蟹CTL序列相似性很高,确定为三疣梭子蟹PtCLec1基因的unigene序列。
5.三疣梭子蟹PtCLec1基因cDNA ORF序列的克隆:根据与PtCLec1基因同源的unigene序列设计特异引物F1(5'ATGAGTCGCTACTTGCTCCTCG 3')和R1(5'GATATTCTTCTCGCAGATACCGAAG 3'),分别利用载体通用引物M13F(5'TGTAAAACGACGGCCAGT 3')和M13R(5'CAGGAAACAGCTATGACC 3')进行扩增PtCLec1的ORF。PCR产物用1%琼脂糖凝胶电泳进行检测,用Axygen胶回收试剂盒进行PCR产物回收和纯化,再与pMD-19T载体(山东赛恩斯科技有限公司)连接,然后转化大肠杆菌感受态DH5α(北京全式金生物技术有限公司),挑选阳性克隆用载体引物M13进行测序,所得结果经SeqMan软件进行拼接,得到三疣梭子蟹PtCLec1基因ORF cDNA序列见SEQ ID No.1。
6.三疣梭子蟹PtCLec1基因cDNA全长序列的扩增:在测序拼接的PtCLec1全长序列上设计扩增5'端的两条特异引物5P1(5'TCCCAAGTGCCAGAGGTAGCGAAGT 3')和5P2(5'TTCTGTGCCGCGATCCACCTTACAT 3'),同理设计扩增3'端的两条特异引物3P1(5'ACGCTAACTTCCTTGCCGACCTTGT 3')和3P2(5'ACCAGCAGTATCCCGATGGAGGAAC 3'),特异引物5P1和3P1分别与100×UPM(5'CTAATACGACTCACTATAGGGCAAGCAGTGGTATCAACGCAGAGT 3')进行5'和3'端的第一次扩增,以cDNA为模板进行全长的验证。特异引物5P2和3P2分别与Nup(5'AAGCAGTGGTAACAACGCAGAGT 3')进行5'和3'端的第二次扩增,以第一次扩增的结果为模板进行全长的验证。测序及分析同5。
ORF扩增反应体系及反应条件:
25μL反应体系:
反应在TaKaRa PCR Thermal Cycler Dice Model TP600(Takara Bio Inc.)中进行,反应条件为:94℃变性3min;94℃变性30s,57.5℃退火50s,72℃延伸1min,35个循环;72℃延伸10min。
5'RACE和3'RACE第一次扩增反应体系及反应条件:
25μL反应体系:
反应在TaKaRa PCR Thermal Cycler Dice Model TP600(Takara Bio Inc.)中进行,反应条件为:98℃变性2min;98℃变性20s,64℃退火30s,72℃延伸2min,5个循环;98℃变性20s,61℃退火30s,72℃延伸2min,8个循环;98℃变性20s,58℃退火30s,72℃延伸2min,25个循环;72℃延伸10min。
5'RACE和3'RACE第二次扩增反应体系及反应条件:
50μL反应体系:
反应在TaKaRa PCR Thermal Cycler Dice Model TP600(Takara Bio Inc.)中进行,反应条件为:98℃变性2min;98℃变性20s,64℃退火30s,72℃延伸2min,5个循环;98℃变性20s,61℃退火30s,72℃延伸2min,8个循环;98℃变性20s,58℃退火30s,72℃延伸2min,25个循环;72℃延伸10min。
序列表SEQ ID No.1从三疣梭子蟹中克隆到PtCLec1基因cDNA全长873bp,其中开放阅读框531bp,5'非翻译区219bp,3'非翻译区123bp,有多聚腺苷酸加尾信号(AATAAA)和多聚腺苷酸尾巴。
实施例2.
三疣梭子蟹C型凝集素序列表SEQ ID No.1所述碱基序列,所述的氨基酸序列如序列表SEQ ID No.2所述。
序列表SEQ ID No.2为:
MSRYLLLAFFGALTVEATTHVNLSDSISGDSSGGCSSPYTMVAGRCLYINFATSGTWDRFHSMYCKDTGGNDLVTVDDANFLADLVQYITSIGWQDGLFWIGASDKSHEGHWIWPNGSPVKMGTPFWGTYGCYNQQYPDGGTNENCAILDGNANLYFNDFKCDTALAVFGICEKNI
其具有完整的编码蛋白含有176个氨基酸,该编码序列有信号肽(1-17),预测的分子量为19.285kDa,等电点为4.45。成熟肽含有159个氨基酸具有典型的CRD结构域(35-173),其中包含4个半胱氨酸残基,能够形成两个二硫键。CRD结构域中缺少典型的脊椎动物和无脊椎动物中识别甘露糖的基序EPN(Glu-Pro-Asn),但含有不常见的YPD基序(Tyr-Pro-Asp),该基序有可能是由识别半乳糖的QPD(Gln-Pro-Asp)变异而来;同时Ca2+结合位点2的第二个基序不是保守的WND(Trp-Asn-Asp)而是FND(Phe-Asn-Asp)。
三疣梭子蟹C型凝集素PtCLec1重组蛋白的获得,具体操作如下:
根据SEQ ID No.2对应的cDNA序列,设计含有限制性内切酶BamHI和XhoI酶切位点的特异性引物F2(5'CGCGGATCCGAACTTATCTGACAGTATCTCC 3')和R2(5'CCGCTCGAGGATATTCTTCTCGCAGATACCGAAG 3'),通过PCR技术扩增编码PtCLec1成熟肽的基因片段(参见图2),反应在TaKaRa PCR Thermal Cycler Dice Model TP600(Takara Bio Inc.)中进行,反应条件为:94℃变性3min;94℃变性30s,57.5℃退火50s,72℃延伸1min,35个循环;最后72℃延伸10min。然后通过酶切将其克隆到pET32a(+)表达载体中,转化到大肠杆菌BL21(DE3)-plysS,测序确认表达框正确后,接种阳性克隆到LB培养基中,37℃振荡培养至OD600nm=0.4~0.6,加入IPTG至终浓度为1mM诱导4h后离心收集菌体。菌体在冰浴条件下用超声波180W处理30min(每次2s,间隔2s),离心去掉上清,收集沉淀。沉淀以8M的尿素溶解后,利用Clontech公司的TALON柱纯化重组产物。将纯化的重组蛋白转移到透析袋中,4℃条件下,在含有2mM还原谷胱苷肽、0.2mM氧化谷胱苷肽、1mM EDTA、50mM Tris-HCl、50mM NaCl、10%甘油和1%甘氨酸的及梯度降低的尿素(6、5、4、3、2、1、0M)的透析复性液(pH=8.0)中透析,使重组蛋白复性,最后在50mM Tris-HCl(pH=8.0)的缓冲液透析2次,以除去溶液中其它成分。透析复性后的重组蛋白经PALL公司的Microsep Advance超滤离心浓缩管进行浓缩,用碧云天公司的BCA蛋白浓度测定试剂盒测得三疣梭子蟹C型凝集素PtCLec1重组蛋白的浓度为1.54mg/mL(参见图3)。
实施例3.
1.三疣梭子蟹C型凝集素PtCLec1重组蛋白的体外抑菌试验:
微生物的培养及制备:溶藻弧菌用TSB培养基28℃培养,副溶血弧菌用TSB培养基28℃培养,铜绿假单胞菌用TSB培养基37℃培养,金黄色葡萄球菌用LB培养基37℃培养,藤黄微球菌用LB培养基37℃培养,毕赤酵母用YPD培养基28℃培养,上述各菌株用摇床220rpm/min培养使菌浓度达到对数生长期时,分别用50mM Tris-HCl(pH=8.0)缓冲液稀释菌体,使其每毫升菌液中的菌落数约为1×103个。
重组蛋白PtCLec1抑菌活性测定:利用上述实施例所得重组蛋白PtCLec1用Tris-HCl(50mM,pH=8.0)梯度稀释(1、1/2、1/4、1/8、1/16、1/32、1/64)后,取50μL加到无菌平底96孔板(Costar,Fisher)中,50μL Tris-HCl(50mM,pH=8.0)设为对照,然后加入50μL稀释好的菌悬液,只加入50μL菌液的孔为空白孔。96孔板在菌液的培养温度下孵育2小时后,加入相应的培养基150μL,空白孔加入培养基至200μL,孵育过夜。加溶藻弧菌、副溶血弧菌、铜绿假单胞菌、毕赤酵母的96孔板在波长为560nm下读数测吸光值,加金黄色葡萄球菌和藤黄微球菌的96孔板在波长为600nm下测量。最小抑菌浓度为微生物可以生长的最大重组蛋白浓度和微生物被完全抑制生长的最低浓度之间的范围。发现上述实施例重组蛋白PtCLec1对革兰氏阴性菌溶藻弧菌、副溶血弧菌和铜绿假单胞菌、革兰氏阳性菌金黄色葡萄球菌和藤黄微球菌有明显的抑制作用,最小抑菌浓度分别为0.48~0.96μM、1.92~3.85μM、0.96~1.92μM、1.92~3.85μM、0.96~1.92μM,而对真菌毕赤酵母没有明显的抑制作用。
2.三疣梭子蟹C型凝集素PtCLec1重组蛋白的体外微生物结合实验
分别取上述培养至对数生长期的细菌、真菌各1.0mL,10000rpm离心1min收集菌体;将收集的菌体用1.0mL 37%的甲醛中固定,37℃轻摇震荡1h。将细菌、真菌于4℃4000rpm离心10min,收集菌体;用1.0mL Tris-HCl缓冲液将菌体洗2次,最后用1.0mL Tris-HCl缓冲液重悬菌体;分别将0.5mL菌悬液与0.5mL PtCLec1重组蛋白混合,4℃轻摇震荡30min后,于4℃4000rpm离心5min;保留上清到新的离心管,用1.0mL Tris-HCl缓冲液将沉淀洗涤2遍,第1次的洗涤液要保留到新的离心管;将菌体重组蛋白结合物与50μL 1×SDS-PAGE上样缓冲液洗脱,将50μL上清液、50.0μL洗涤液分别与50μL 5×SDS-PAGE上样缓冲液混匀;分别将洗脱液、上清液、洗涤液进行15%SDS-PAGE电泳(参见图4)。由图4可见,上述实施例重组蛋白PtCLec1对革兰氏阴性菌溶藻弧菌、副溶血弧菌和铜绿假单胞菌、革兰氏阳性菌金黄色葡萄球菌和藤黄微球菌以及真菌毕赤酵母菌均有结合活力。
3.三疣梭子蟹C型凝集素PtCLec1重组蛋白的体外微生物凝集实验
FITC染色:分别取上述培养至对数生长期的细菌、真菌1.0mL,于4℃4000rpm离心5min收集菌体,弃去培养基后用PBS洗菌3次。加入终浓度为0.1mg mL-1的FITC,暗处慢摇染色过夜。于4℃4000rpm离心5min收集菌体,弃去培养基后用PBS洗菌3次,以去除残留的FITC。
凝菌实验:使用无菌PBS将FITC标记的菌重悬,调整菌浓度至2.5×109个mL-1。实验组中,取25μL PtCLec1重组蛋白与20μL FITC标记的菌悬液于1.5mL离心管中混匀;对照组中,取25μL rTrx与20μL FITC标记的菌悬液混匀。为观察Ca2+是否对凝集活性有影响,在实验组和对照组中分别加入10mM CaCl2和用10mM EDTA螯合Ca2+。将样品置于暗处28℃慢摇孵育2h,取5μL于荧光显微镜下观察(参见图5)。由图5可见,上述实施例重组蛋白PtCLec1在Ca2+存在下对革兰氏阴性菌溶藻弧菌、副溶血弧菌和铜绿假单胞菌、革兰氏阳性菌金黄色葡萄球菌和藤黄微球菌以及真菌毕赤酵母菌均有显著的凝集作用。
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。
序列表
<110> 中国科学院海洋研究所
<120> 三疣梭子蟹C型凝集素PtCLec1基因及其编码蛋白和应用
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 873
<212> DNA
<213> 三疣梭子蟹(Portunus trituberculatus)
<400> 1
gtaagaatga ctgttgggtg tttctccgta cagccactct tatgggaaag ccggtctgtt 60
cgtagtacaa tgcagagata ggggttcggc ttgcgcaaga cgagagcacc agcaaaacag 120
tcgtgcatat atgtaaggtg gatcgcggca cagaacagca cacatcctcc ttcagctgca 180
cactttgcct ccacctgctc cgccgccaac acttgcatca tgagtcgcta cttgctcctc 240
gcattcttcg gagccttgac tgtggaggcg acgacacatg tgaacttatc tgacagtatc 300
tccggtgatt cttcgggggg ctgcagctcc ccgtacacta tggttgctgg ccgctgctta 360
tacattaact tcgctacctc tggcacttgg gaccgcttcc actccatgta ctgcaaagac 420
acaggaggga atgacctggt gacagtggac gacgctaact tccttgccga ccttgttcag 480
tacatcacaa gtattggatg gcaagacggt ttgttctgga tcggtgcctc ggacaagagt 540
cacgagggcc actggatatg gcctaacggc tcccccgtca agatgggtac acccttctgg 600
ggcacgtacg gctgctacaa ccagcagtat cccgatggag gaaccaatga aaactgcgca 660
atactagatg gaaatgcaaa tctatatttc aacgacttta aatgtgacac agcattagct 720
gtcttcggta tctgcgagaa gaatatctag gaaaattatt gagcttataa tttagtaata 780
atgtatgtca catatgataa gccataagaa gcaagacagg aaatgtactc taaagcaata 840
aaaacgaaaa tataaaaaaa aaaaaaaaaa aaa 873
<210> 2
<211> 176
<212> PRT
<213> 三疣梭子蟹(Portunus trituberculatus)
<400> 2
Met Ser Arg Tyr Leu Leu Leu Ala Phe Phe Gly Ala Leu Thr Val Glu
1 5 10 15
Ala Thr Thr His Val Asn Leu Ser Asp Ser Ile Ser Gly Asp Ser Ser
20 25 30
Gly Gly Cys Ser Ser Pro Tyr Thr Met Val Ala Gly Arg Cys Leu Tyr
35 40 45
Ile Asn Phe Ala Thr Ser Gly Thr Trp Asp Arg Phe His Ser Met Tyr
50 55 60
Cys Lys Asp Thr Gly Gly Asn Asp Leu Val Thr Val Asp Asp Ala Asn
65 70 75 80
Phe Leu Ala Asp Leu Val Gln Tyr Ile Thr Ser Ile Gly Trp Gln Asp
85 90 95
Gly Leu Phe Trp Ile Gly Ala Ser Asp Lys Ser His Glu Gly His Trp
100 105 110
Ile Trp Pro Asn Gly Ser Pro Val Lys Met Gly Thr Pro Phe Trp Gly
115 120 125
Thr Tyr Gly Cys Tyr Asn Gln Gln Tyr Pro Asp Gly Gly Thr Asn Glu
130 135 140
Asn Cys Ala Ile Leu Asp Gly Asn Ala Asn Leu Tyr Phe Asn Asp Phe
145 150 155 160
Lys Cys Asp Thr Ala Leu Ala Val Phe Gly Ile Cys Glu Lys Asn Ile
165 170 175
Claims (4)
1.一种三疣梭子蟹C型凝集素PtCLec1基因,其特征在于:三疣梭子蟹C型凝集素PtCLec1基因为序列表SEQ ID No.1中的碱基序列所示。
2.一种权利要求1所述的三疣梭子蟹C型凝集素PtCLec1基因编码蛋白,其特征在于:所述PtCLec1基因编码蛋白为序列表SEQ ID No.2中的氨基酸序列所示。
3.一种按权利要求2所述的三疣梭子蟹C型凝集素PtCLec1基因编码蛋白的应用,其特征在于:
所述三疣梭子蟹C型凝集素PtCLec1基因的重组表达产物用于制备溶藻弧菌、副溶血弧菌、铜绿假单胞菌、金黄色葡萄球菌或藤黄微球菌的抗菌药物。
4.一种按权利要求2所述的三疣梭子蟹C型凝集素PtCLec1基因编码蛋白的应用,其特征在于:所述三疣梭子蟹C型凝集素PtCLec1基因的重组表达产物用于制备溶藻弧菌、副溶血弧菌、铜绿假单胞菌、金黄色葡萄球菌、藤黄微球菌或毕赤酵母菌的抗菌药物、菌结合制剂或凝集制剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910644066.7A CN110343703B (zh) | 2019-07-17 | 2019-07-17 | 三疣梭子蟹C型凝集素PtCLec1基因及其编码蛋白和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910644066.7A CN110343703B (zh) | 2019-07-17 | 2019-07-17 | 三疣梭子蟹C型凝集素PtCLec1基因及其编码蛋白和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110343703A CN110343703A (zh) | 2019-10-18 |
CN110343703B true CN110343703B (zh) | 2022-12-27 |
Family
ID=68176665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910644066.7A Active CN110343703B (zh) | 2019-07-17 | 2019-07-17 | 三疣梭子蟹C型凝集素PtCLec1基因及其编码蛋白和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110343703B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110791572B (zh) * | 2019-12-02 | 2021-06-08 | 中国水产科学研究院黄海水产研究所 | 一种三疣梭子蟹耐副溶血弧菌的分子标记c7及其应用 |
CN110724750B (zh) * | 2019-12-02 | 2021-06-04 | 中国水产科学研究院黄海水产研究所 | 一种三疣梭子蟹耐副溶血弧菌的分子标记c242及其应用 |
CN113234132B (zh) * | 2021-04-12 | 2022-06-17 | 浙江理工大学 | 一种拟穴青蟹c型凝集素及其制备方法和应用 |
CN117327706A (zh) * | 2023-10-13 | 2024-01-02 | 江苏三仪生物工程有限公司 | 一种用于提高水产抗病毒和免疫能力的组合物及其应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101421295A (zh) * | 2006-02-09 | 2009-04-29 | 先锋高级育种国际公司 | 用于提高作物植物中的氮利用效率的基因 |
JP2009538603A (ja) * | 2006-06-02 | 2009-11-12 | ヒューマン ジェネティック シグネチャーズ ピーティーワイ リミテッド | 微生物の検出および分析に使用するための微生物改変核酸 |
CN102321628A (zh) * | 2011-08-01 | 2012-01-18 | 武汉凯肽来生物科技有限公司 | 一种克氏原螯虾c-型凝集素基因及制备方法和应用 |
CN103387978A (zh) * | 2013-07-24 | 2013-11-13 | 浙江省淡水水产研究所 | 三疣梭子蟹c-型凝集素基因多态性标记及snp分子标记基因分型的方法 |
CN108558994A (zh) * | 2018-04-17 | 2018-09-21 | 中国科学院海洋研究所 | 三疣梭子蟹C1q受体PtgC1qR基因及其编码蛋白和应用 |
CN110317813A (zh) * | 2019-07-17 | 2019-10-11 | 中国科学院海洋研究所 | 三疣梭子蟹C型凝集素PtCLec2基因及其编码蛋白和应用 |
-
2019
- 2019-07-17 CN CN201910644066.7A patent/CN110343703B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101421295A (zh) * | 2006-02-09 | 2009-04-29 | 先锋高级育种国际公司 | 用于提高作物植物中的氮利用效率的基因 |
JP2009538603A (ja) * | 2006-06-02 | 2009-11-12 | ヒューマン ジェネティック シグネチャーズ ピーティーワイ リミテッド | 微生物の検出および分析に使用するための微生物改変核酸 |
CN102321628A (zh) * | 2011-08-01 | 2012-01-18 | 武汉凯肽来生物科技有限公司 | 一种克氏原螯虾c-型凝集素基因及制备方法和应用 |
CN103387978A (zh) * | 2013-07-24 | 2013-11-13 | 浙江省淡水水产研究所 | 三疣梭子蟹c-型凝集素基因多态性标记及snp分子标记基因分型的方法 |
CN108558994A (zh) * | 2018-04-17 | 2018-09-21 | 中国科学院海洋研究所 | 三疣梭子蟹C1q受体PtgC1qR基因及其编码蛋白和应用 |
CN110317813A (zh) * | 2019-07-17 | 2019-10-11 | 中国科学院海洋研究所 | 三疣梭子蟹C型凝集素PtCLec2基因及其编码蛋白和应用 |
Non-Patent Citations (3)
Title |
---|
C-type lectin 1 [Portunus trituberculatus];Su,Y.等;《NCBI》;20200304;ACCESSION NO.QIE05465 * |
Portunus trituberculatus C-type lectin 1 (CLec1) mRNA, complete cds;Su,Y.等;《NCBI》;20200304;ACCESSION NO.MN394839 * |
三疣梭子蟹C-型凝集素的原核表达和活性检测;于金红等;《渔业科学进展》;20131015(第05期);第60-65页 * |
Also Published As
Publication number | Publication date |
---|---|
CN110343703A (zh) | 2019-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110343703B (zh) | 三疣梭子蟹C型凝集素PtCLec1基因及其编码蛋白和应用 | |
CN109797155B (zh) | 三疣梭子蟹甘露糖结合凝集素PtMBL基因及其编码蛋白和应用 | |
CN110643612B (zh) | 一种卵形鲳鲹抗菌肽NK-lysin基因及应用 | |
CN113831395B (zh) | 一种重组抗菌肽TrSub、制备方法及其应用 | |
CN110317813B (zh) | 三疣梭子蟹C型凝集素PtCLec2基因及其编码蛋白和应用 | |
CN110551732A (zh) | 一种卵形鲳鲹抗菌肽leap-2基因及应用 | |
CN107937406B (zh) | 一种三疣梭子蟹新型Crustin基因及其重组蛋白的应用 | |
CN103160525A (zh) | 一种紫贻贝g型溶菌酶基因及其重组蛋白和应用 | |
CN108558994B (zh) | 三疣梭子蟹C1q受体PtgC1qR基因及其编码蛋白和应用 | |
CN112301010B (zh) | 一种胺氧化酶acao、制备方法和应用 | |
CN101525617B (zh) | 中华绒螯蟹Crustin-1基因及体外重组表达 | |
CN112877334B (zh) | 三疣梭子蟹纤维蛋白原相关蛋白PtFREP基因及其编码蛋白和应用 | |
CN112877335B (zh) | 三疣梭子蟹血管生成素PtANG基因及其编码蛋白和应用 | |
CN103739696B (zh) | 一种半滑舌鳎雌性特异csw3蛋白及其基因与应用 | |
CN107746432B (zh) | 一种Aβ42修饰蛋白及其表达与纯化方法 | |
CN113912691B (zh) | 重组长牡蛎高迁移率族蛋白r-CgHMGB1、制备方法及其应用 | |
CN101565703B (zh) | 中华绒螯蟹Crustin-2基因及其重组蛋白的应用 | |
JPH04506800A (ja) | ソマトトロピン類似体 | |
CN109293751B (zh) | 鼠疫耶尔森菌毒力相关蛋白sORF34及其编码基因与应用 | |
CN106811526B (zh) | 一种拟穴青蟹抗病性状的cSNP分子标记检测试剂盒及检测方法 | |
CN110257409B (zh) | 一种红螯螯虾孵化酶基因及其应用 | |
CN111690636A (zh) | 一种胰蛋白酶样丝氨酸蛋白酶基因、编码的蛋白质和应用 | |
CN113817696B (zh) | 一种胺氧化酶asao、制备方法和应用 | |
CN116987173A (zh) | 凡纳滨对虾甘露糖受体LvMR重组蛋白的应用 | |
CN116617364A (zh) | 凡纳滨对虾C型甘露糖受体LvCTMR重组蛋白的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |